ACETAMINOPHEN CHLORPHENIRAMINE MALEATE PHENYLEPHERINE HYDROCHLORIDE

ACETAMINOPHEN CHLORPHENIRAMINE MALEATE PHENYLEPHERINE HYDROCHLORIDE was reported 43 times

ACETAMINOPHEN CHLORPHENIRAMINE MALEATE PHENYLEPHERINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINE CHLORIDE DECREASED 1 0.0417
1 THERMOANAESTHESIA 1 0.0270
2 URINE SODIUM DECREASED 1 0.0077
3 PSEUDOALDOSTERONISM 1 0.0051
4 PHARMACEUTICAL PRODUCT COUNTERFEIT 1 0.0048
5 MENIERE'S DISEASE 1 0.0029
6 CIRCUMORAL OEDEMA 1 0.0029
7 EXANTHEM 1 0.0028
8 ENCEPHALITIS HERPES 1 0.0020
9 CLONIC CONVULSION 1 0.0014
10 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
11 MUCOUS MEMBRANE DISORDER 1 0.0007
12 MYOGLOBIN BLOOD INCREASED 1 0.0007
13 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
14 BLOOD CALCIUM ABNORMAL 1 0.0006
15 BLOOD CHLORIDE INCREASED 1 0.0006
16 RENAL CANCER STAGE II 1 0.0006
17 UTERINE SPASM 1 0.0005
18 INTENTIONAL MISUSE 1 0.0005
19 DRUG SCREEN POSITIVE 4 0.0005
20 FEAR OF DEATH 1 0.0004
21 DIABETES INSIPIDUS 1 0.0004
22 HYPERPARATHYROIDISM SECONDARY 1 0.0004
23 MEDICATION RESIDUE 1 0.0004
24 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
25 PARANASAL SINUS HYPERSECRETION 1 0.0003
26 FEELING OF DESPAIR 1 0.0002
27 ABORTION INDUCED 2 0.0002
28 SARCOIDOSIS 1 0.0002
29 DRUG TOLERANCE 1 0.0002
30 CACHEXIA 1 0.0002
31 DENTAL CARIES 2 0.0002
32 HYPERVENTILATION 1 0.0002
33 SINUS HEADACHE 1 0.0002
34 DYSGRAPHIA 1 0.0002
35 APPETITE DISORDER 1 0.0002
36 FORMICATION 1 0.0001
37 MAJOR DEPRESSION 1 0.0001
38 GINGIVAL PAIN 1 0.0001
39 UTERINE CANCER 1 0.0001
40 SENSORY LOSS 1 0.0001
41 WRONG DRUG ADMINISTERED 1 0.0001
42 MOTOR DYSFUNCTION 1 0.0001
43 NEUTROPHIL COUNT INCREASED 1 0.0001
44 UNINTENDED PREGNANCY 1 0.0001
45 RESPIRATORY DEPRESSION 1 0.0001
46 SEASONAL ALLERGY 1 0.0001
47 DRUG ADMINISTRATION ERROR 2 0.0001
48 MUSCLE TIGHTNESS 1 0.0001
49 BLOOD UREA INCREASED 1 0.0001
50 LYMPHOCYTE COUNT DECREASED 1 0.0001
51 BLOOD SODIUM DECREASED 1 0.0001
52 PROTEINURIA 1 0.0001
53 GLAUCOMA 1 0.0001
54 NASAL CONGESTION 3 0.0001
55 MENORRHAGIA 1 0.0001
56 IMPAIRED WORK ABILITY 1 0.0000
57 PRURITUS GENERALISED 1 0.0000
58 ORAL PAIN 1 0.0000
59 TINNITUS 2 0.0000
60 CEREBRAL INFARCTION 1 0.0000
61 UNRESPONSIVE TO STIMULI 1 0.0000
62 SPEECH DISORDER 2 0.0000
63 MENSTRUATION IRREGULAR 1 0.0000
64 ABNORMAL DREAMS 1 0.0000
65 PAIN IN JAW 1 0.0000
66 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
67 BLOOD POTASSIUM DECREASED 1 0.0000
68 APHASIA 1 0.0000
69 LIP SWELLING 1 0.0000
70 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
71 NIGHTMARE 1 0.0000
72 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
73 C-REACTIVE PROTEIN INCREASED 1 0.0000
74 PANIC ATTACK 1 0.0000
75 RESTLESSNESS 1 0.0000
76 HEPATIC FUNCTION ABNORMAL 1 0.0000
77 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
78 DISORIENTATION 1 0.0000
79 RHABDOMYOLYSIS 1 0.0000
80 HYPOACUSIS 1 0.0000
81 THROAT IRRITATION 1 0.0000
82 SUICIDAL IDEATION 2 0.0000
83 OROPHARYNGEAL PAIN 2 0.0000
84 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
85 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
86 DRUG EFFECT DECREASED 1 0.0000
87 DISTURBANCE IN ATTENTION 1 0.0000
88 ANAPHYLACTIC REACTION 1 0.0000
89 PRODUCT SUBSTITUTION ISSUE 1 0.0000
90 DYSPHONIA 1 0.0000
91 SUICIDE ATTEMPT 1 0.0000
92 ILL-DEFINED DISORDER 1 0.0000
93 NASOPHARYNGITIS 3 0.0000
94 EXPOSURE DURING PREGNANCY 1 0.0000
95 SWELLING FACE 1 0.0000
96 BLOOD CREATININE INCREASED 1 0.0000
97 RENAL FAILURE 2 0.0000
98 HYPOAESTHESIA 2 0.0000
99 CHRONIC KIDNEY DISEASE 1 0.0000
100 INJECTION SITE SWELLING 1 0.0000
101 TOXICITY TO VARIOUS AGENTS 2 0.0000
102 BALANCE DISORDER 1 0.0000
103 MUSCULOSKELETAL STIFFNESS 1 0.0000
104 DRUG WITHDRAWAL SYNDROME 1 0.0000
105 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
106 SWELLING 1 0.0000
107 ANXIETY 3 0.0000
108 DYSPHAGIA 1 0.0000
109 SYNCOPE 1 0.0000
110 SINUSITIS 1 0.0000
111 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
112 HAEMORRHAGE 1 0.0000
113 MALAISE 4 0.0000
114 ASTHMA 1 0.0000
115 PYREXIA 3 0.0000
116 DECREASED APPETITE 2 0.0000
117 PALPITATIONS 1 0.0000
118 OEDEMA PERIPHERAL 1 0.0000
119 INJECTION SITE ERYTHEMA 1 0.0000
120 LOSS OF CONSCIOUSNESS 1 0.0000
121 PRODUCT QUALITY ISSUE 1 0.0000
122 INFECTION 1 0.0000
123 ACUTE KIDNEY INJURY 1 0.0000
124 DRUG INTERACTION 1 0.0000
125 CONFUSIONAL STATE 1 0.0000
126 COVID-19 1 0.0000
127 MUSCLE SPASMS 1 0.0000
128 CHEST PAIN 1 0.0000
129 BLOOD GLUCOSE INCREASED 1 0.0000
130 ANAEMIA 1 0.0000
131 ABDOMINAL PAIN UPPER 1 0.0000
132 WEIGHT INCREASED 1 0.0000
133 VOMITING 2 0.0000
134 FEELING ABNORMAL 1 0.0000
135 DIZZINESS 2 0.0000
136 FATIGUE 3 0.0000
137 NAUSEA 3 0.0000
138 INSOMNIA 1 0.0000
139 DYSPNOEA 2 0.0000
140 HEADACHE 2 0.0000
141 PNEUMONIA 1 0.0000
142 FALL 1 0.0000
143 PRURITUS 1 0.0000
144 RASH 1 0.0000
145 DRUG INEFFECTIVE 3 0.0000